BresaGen, Cythera complete merger
Friday, 09 July, 2004
The merger between Bresagen's US subsidiary Bresagen Inc and San Diego stem cell company Cythera has been completed.
The Adelaide-based company's administrators said the merger was executed on 28 June 2004.
According to the merger agreement, which was announced last month, the merger of Bresagen and Cythera was to be accompanied by a US$5 million capital raising. Bresagen (ASX:BGN) will own about 30 per cent of the combined entity and have a seat on the board.
Bresagen and Cythera initially announced the deal in November last year, but in January the Australian company went in to voluntary administration after plans to spin out its Australian protein pharmaceuticals division derailed. The division has since been acquired by Queensland-based CBio in a restructuring deal.
The University of Sydney formalises cervical cancer elimination partnership
The success of a cervical cancer elimination program has led to the signing of a memorandum of...
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
